Advanced search
Publication Cover
Leukemia & Lymphoma Volume 63, 2022 - Issue 13
Submit an article Journal homepage
515
Views
1
CrossRef citations to date
0
Altmetric
Articles

Final results of brentuximab vedotin combined with ifosfamide-carboplatin-etoposide in first refractory/relapsed Hodgkin lymphoma: a lymphoma study association phase I/II study

Aspasia Stamatoullasa Département d’Hématologie, Centre Henri Becquerel, Rouen, FranceCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-7321-5254
ORCID Icon,
Hervé Ghesquièresb Département d’Hématologie, Centre Hospitalier Lyon Sud, Lyon FranceORCID Iconhttps://orcid.org/0000-0002-3131-3718
ORCID Icon,
Pierre Feugierc Département d’Hématologie, CHU Nancy, Nancy, France
,
Marc Andréd Département d’Hématologie, CHU UCL, Namur, Belgique
,
Fabien Le Brase Unité Hémopathies Lymphoïdes, Hôpital Henri Mondor, Créteil, France
,
Anne-Claire Gacf Département d’Hématologie, CHU, Caen, France
,
Cécile Borelg Département d’Hématologie, IUCT Oncopole, Toulouse, France
,
Thomas Gastinneh Département d’Hématologie, CHU Nantes, Nantes, France
,
Philippe Quitteti Département d’Hématologie, CHU Montpellier, Montpellier, France
,
Franck Morschhauserj Département d’Hématologie, CHRU Lille, Lille, France
,
Vincent Ribragk Département of Hématologie, Institut Gustave Roussy, Paris, France
,
Stephanie Guidezl Service d'Oncologie Hématologique et Thérapie Cellulaire, CHU Poitiers, Poitiers, France
,
Emmanuelle Nicolas-Virelizierm Service d’Hématologie, Centre Léon Bérard, Lyon, France
,
Alina Berriolo-Riedingern Service de Médecine Nucléaire, Centre GF Leclerc, Dijon, France
,
Thierry Vander Borghto Service de médecine Nucléaire, CHU UCL Namur, Namur, Belgique
,
Véronique Edelinep Service de Médecine Nucléaire, Institut Curie, Hôpital R Huguenin, Saint-Cloud, France
&
Pauline Briceq Département d’Hématologie, Hôpital Saint Louis, APHP Paris, Paris, France
 show all
Pages 3063-3071 | Received 20 May 2022, Accepted 23 Jul 2022, Published online: 17 Aug 2022

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.